Our Consumer Healthcare business develops and markets a range of products in the areas of: Pain Relief, Respiratory, Oral Health, Nutrition/Gastro Intestinal and Skin Health. These include a number of well-known global brands such as Sensodyne, Voltaren and Panadol.
We develop and market a range of over-the-counter consumer healthcare products across oral health, pain relief, nutritional/gastrointestinal, respiratory and skin health. Panadol, Sensodyne and Macleans are some of our well known consumer healthcare brands in Australia.
Our strong research and scientific heritage contributes to the credibility of our consumer healthcare products. Today, we are using science to speed up the time it takes to develop new products and to make them more accessible to the people who need them.
One of our most noted consumer healthcare products - Panadol - has been manufactured in Ermington, Sydney’s north west, since 1959. Each year this manufacturing plant produces more than 50 million packs of Panadol and 5.5 million bottles of paediatric liquids.
Our Australian Consumer Healthcare business is the latest to launch the GSK Open Innovation programme – our global campaign to support new innovations to promote change beyond GSK by sharing expertise, resources, intellectual property and know-how with the broader scientific community.
Changes to our Consumer Healthcare business completed
In June 2016, we completed a three-part transaction with Novartis which re-shapes our business.
We have combined our consumer healthcare business with Novartis’s to create one of the world’s largest consumer healthcare companies, with number one positions in specialist oral health and over-the-counter medicines across 36 markets and leading positions in skin health and family nutrition.
Are you an Australian or New Zealand researcher, innovator or entrepreneur with the next great healthcare product innovation?